Trials / Sponsors / TaiwanJ Pharmaceuticals Co., Ltd
TaiwanJ Pharmaceuticals Co., Ltd
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH) Autoimmune Hepatitis | Phase 2 | 2020-11-01 |
| Unknown | A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule Autoimmune Hepatitis | Phase 1 | 2020-08-01 |
| Unknown | A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis Nonalcoholic Steatohepatitis (NASH) With Fibrosis | Phase 2 | 2020-06-30 |
| Completed | Liver Test Study of Using JKB-122 in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to C Autoimmune Hepatitis | Phase 2 | 2016-04-30 |
| Terminated | Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interfer Chronic Hepatitis C | Phase 2 | 2014-05-01 |